BusinessHemispherx Biopharma Featured in Corporate America News Magazine Special Report “Capturing the Power of Immune Response to Treat Disease: Biotech Bounce Back”By Nasdaq OMXNov 8, 2016, 1:30 PM UTC
BusinessHemispherx Biopharma Europe N.V./S.A. : Orphan Medicine Designation and European Medicines Agency Public Opinion Summary Published by EMA Regarding Alferon N Injection® as a Treatment of Middle East Respiratory Syndrome (MERS)By Nasdaq OMXJan 20, 2016, 1:30 PM UTC
